Patients with osteoarthritis (OA) of the knee receiving an investigational chemokine inhibitor showed some improvements in ...

GSK is pumping £50 million (about $65 million) into a five-year collaboration with the University of Cambridge and Cambridge ...

The Cambridge-GSK Translational Immunology Collaboration builds on an existing scientific relationship between the biopharma company and the university, with the aim of improving outcomes for patients ...

GSK has announced a £50m ($54.3m) investment in a new partnership with the University of Cambridge and Cambridge University ...

DelveInsight's 'JAK Inhibitors Pipeline Insight 2024' report provides comprehensive global coverage of pipeline JAK ...

The launch of the GSK ‘Understanding Shingles’ research findings aims to raise awareness and address the lack of knowledge ...

The rising cost of living continues to hit Nigerian households and the latest example is the price of toothpaste, which is ...

HUL's board will announce dividend fir its shareholders today. HUL dividend 2024 record date has already been fixed by the ...

Asthma affects approximately 262 million people globally, with the number of asthma incidents having increased by around 15% ...

Avacta Therapeutics has entered a strategic collaboration with Tempus AI to advance the development of drugs in oncology.

In patients with moderate to severe Crohn’s disease, guselkumab showed similar efficacy in both biologic-naive and ...

Syringes are expected to dominate the market as the highest revenue-generating segment. The report forecasts that the ...